Dr. Reddy's Laboratories Limited
DRREDDYDrug Manufacturers - Specialty & Generic
₹1,352.00+0.52%As of Oct 30vs prior close
- Market cap
- $11.9B
- P/E (TTM)
- 40.3×
- P/E (FY1)
- 30.4×
- From 52W high
- −1.10%
- EPS (LTM)
- ₹33.59
- Revenue (LTM)
- ₹329.8B
- Net margin
- 8.48%
- Dividend yield
- 0.59%
Nomior Score
56
Steady ProfileTop 36% of the scored universe
Growth61
Quality47
Value50
Momentum51
Resilience62
Growth
+10.96%revenue a year over 3 fiscal years
YE23 ₹245.9BLTM ₹329.8B
Connections
Revenue to profitYE26
13% of revenue became net profit, down 5 pts on a year.